Hodges Capital Management’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-18,900
Closed -$618K 248
2021
Q4
$618K Sell
18,900
-98,566
-84% -$3.97M 0.04% 180
2021
Q3
$4.82M Sell
117,466
-362,295
-76% -$13.1M 0.35% 86
2021
Q2
$17.3M Buy
479,761
+138,336
+41% +$5.11M 1.94% 7
2021
Q1
$13.3M Buy
341,425
+298,750
+700% +$13.4M 1.84% 8
2020
Q4
$1.72M Buy
+42,675
New +$1.96M 0.27% 109

Other funds holding GDRX

Hodges Capital Management's GDRX Position: Q1 2022 in Review

Hodges Capital Management sold out of GoodRx Holdings (GDRX) in Q1 2022, closing a stake of 18,900 shares — an estimated $618K sold.

Hodges Capital Management first reported a position in GDRX in Q4 2020 and held it in 5 quarters. The position peaked at $17.3M in Q2 2021. 167 funds tracked by Wall St. Rank hold GDRX as of Q1 2022.

  • Hodges Capital Management reported no remaining GoodRx Holdings position as of Q1 2022 after selling out during the quarter.
  • Hodges Capital Management sold 18,900 GoodRx Holdings shares in Q1 2022, an estimated $618K.
  • Hodges Capital Management first reported a position in GoodRx Holdings in Q4 2020 and held it in 5 quarters.
  • Hodges Capital Management's GoodRx Holdings position peaked at $17.3M in Q2 2021.
  • 167 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2022.

Based on Hodges Capital Management's 13F filing for Q1 2022, filed 12 May 2022.